Ziwen Pan

1.6k citations
14 papers · 549 indexed · 1 hit paper · h-index 11
Topics
MicroRNA in disease regulation (8 papers)Extracellular vesicles in disease (7 papers)RNA modifications and cancer (5 papers)
Partner nations
ChinaUnited StatesNorway

In The Last Decade

Ziwen Pan

14 papers receiving 546 citations

Hit Papers

Synchronous Disintegration of Ferroptosis Defense Axis vi...2022202620232024202250100150

Peers

Ziwen Pan
Comparison fields: 5 of 65
  • Molecular Biology 376
  • Cancer Research 238
  • Immunology 112
  • Biomedical Engineering 94
  • Pulmonary and Respiratory Medicine 71
Replace Zhongye Xu with:
Zhongye Xu China
Taoliang Chen China
Caijun Zha China
Jagoda K. Hebda France
Saeideh Ebrahimkhani Australia
Baohua Jiao China
Isabele Cristiana Iser Brazil
Veronica De Gregorio Italy
Yue Zhong China
Ziwen Pan relative to Zhongye Xu China Zhongye Xu's profile →
Citations per field
00.5×5.8×
Zhongye Xu · 1×
Citations per year

Countries citing papers authored by Ziwen Pan

Since Specialization
Citations

This map shows the geographic impact of Ziwen Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziwen Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziwen Pan more than expected).

Fields of papers citing papers by Ziwen Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziwen Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziwen Pan. The network helps show where Ziwen Pan may publish in the future.

Co-authorship network of co-authors of Ziwen Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Ziwen Pan. A scholar is included among the top collaborators of Ziwen Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziwen Pan. Ziwen Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 7
2 10
3 5
4 4
5 25
6 31
7 26
8 19
9 85
10 21
11 29
12
Synchronous Disintegration of Ferroptosis Defense Axis via Engineered Exosome‐Conjugated Magnetic Nanoparticles for Glioblastoma Therapybreakdown →
157
13 40
14 90

About Ziwen Pan

Ziwen Pan is a scholar working on Cancer Research, Molecular Biology and Immunology, having authored 14 papers that have together received 549 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), Extracellular vesicles in disease (7 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Cancer Research (238 citations), Genetics (67 citations) and Molecular Biology (376 citations). Ziwen Pan has collaborated with scholars based in China, United States and Norway. Frequent co-authors include Yanhua Qi, Boyan Li, Hao Xue, Gang Li, Rongrong Zhao, Wei Qiu, Shulin Zhao, Qindong Guo, Shouji Zhang and Zijie Gao. Their work appears in journals such as ACS Nano, Cancer Research and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026